A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Jacobio Pharmaceuticals Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
Seagen Inc.
Hoffmann-La Roche
Incyte Corporation
Allist Pharmaceuticals, Inc.
Exelixis
Keythera (Suzhou) Pharmaceuticals Co. Ltd
Jacobio Pharmaceuticals Co., Ltd.
AstraZeneca
OHSU Knight Cancer Institute
University of Michigan Rogel Cancer Center
Hoag Memorial Hospital Presbyterian